|
Underweight |
Normal Weight |
Overweight |
Obese |
Morbidly Obese |
Ext. Mor. Obese |
|
Variable |
N |
% |
N |
% |
N |
% |
N |
% |
N |
% |
N |
% |
p-value |
Recipient Characteristics |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gender |
|
|
|
|
|
|
|
|
|
|
|
|
<.001 |
Female |
18 |
78.26 |
126 |
47.19 |
89 |
33.71 |
62 |
41.06 |
20 |
39.22 |
3 |
27.27 |
|
Race |
|
|
|
|
|
|
|
|
|
|
|
|
<.001† |
African American |
5 |
21.74 |
38 |
14.23 |
53 |
20.08 |
30 |
19.87 |
14 |
27.45 |
4 |
36.36 |
|
Other |
3 |
13.04 |
37 |
13.86 |
43 |
16.29 |
15 |
9.93 |
3 |
5.88 |
1 |
9.09 |
|
White |
15 |
65.22 |
192 |
71.91 |
168 |
63.64 |
106 |
70.20 |
34 |
66.67 |
6 |
54.55 |
|
Ethnicity |
|
|
|
|
|
|
|
|
|
|
|
|
0.388† |
Hispanic |
1 |
4.35 |
19 |
7.12 |
30 |
11.36 |
12 |
7.95 |
2 |
3.92 |
0 |
0.00 |
|
Age (years) |
|
|
|
|
|
|
|
|
|
|
|
|
0.007† |
18 - 30 |
2 |
8.70 |
25 |
9.36 |
17 |
6.44 |
5 |
3.31 |
1 |
1.96 |
0 |
0.00 |
|
31 - 44 |
12 |
52.17 |
113 |
42.32 |
83 |
31.44 |
41 |
27.15 |
14 |
27.45 |
4 |
36.36 |
|
45 - 59 |
7 |
30.43 |
92 |
34.46 |
114 |
43.18 |
79 |
52.32 |
25 |
49.02 |
6 |
54.55 |
|
> 60 |
2 |
8.70 |
37 |
13.86 |
50 |
18.94 |
26 |
17.22 |
11 |
21.57 |
1 |
9.09 |
|
Primary cause of ESRD |
|
|
|
|
|
|
|
|
|
|
|
|
0.727† |
Diabetes mellitus |
6 |
26.09 |
115 |
43.07 |
107 |
40.53 |
56 |
37.09 |
19 |
37.25 |
4 |
36.36 |
|
Glomerulonephritis |
8 |
34.78 |
50 |
18.73 |
53 |
20.08 |
31 |
20.53 |
11 |
21.57 |
1 |
9.09 |
|
PKD |
3 |
13.04 |
24 |
8.99 |
30 |
11.36 |
17 |
11.26 |
3 |
5.88 |
2 |
18.18 |
|
Hypertension |
3 |
13.04 |
36 |
13.48 |
44 |
16.67 |
25 |
16.56 |
6 |
11.76 |
3 |
27.27 |
|
Unknown |
0 |
0.00 |
1 |
0.37 |
3 |
1.14 |
1 |
0.66 |
0 |
0.00 |
0 |
0.00 |
|
Other |
3 |
13.04 |
41 |
15.36 |
27 |
10.23 |
21 |
13.91 |
12 |
23.53 |
1 |
9.09 |
|
Pre-Transplant Dialysis Duration |
|
|
|
|
|
|
|
|
|
|
|
|
0.446† |
None (pre-emptive) |
3 |
13.04 |
68 |
25.47 |
52 |
19.70 |
25 |
16.56 |
8 |
15.69 |
2 |
18.18 |
|
> 0 - 12 months |
5 |
21.74 |
51 |
19.10 |
52 |
19.70 |
29 |
19.21 |
7 |
13.73 |
1 |
9.09 |
|
> 12 - 24 months |
4 |
17.39 |
60 |
22.47 |
62 |
23.48 |
28 |
18.54 |
9 |
17.65 |
3 |
27.27 |
|
> 25 - 60 months |
7 |
30.43 |
66 |
24.72 |
77 |
29.17 |
51 |
33.77 |
22 |
43.14 |
5 |
45.45 |
|
> 60 months |
4 |
17.39 |
22 |
8.24 |
21 |
7.95 |
18 |
11.92 |
5 |
9.80 |
0 |
0.00 |
|
Diabetes |
7 |
30.43 |
120 |
44.94 |
125 |
47.35 |
64 |
42.38 |
20 |
39.22 |
6 |
54.55 |
0.546 |
PVD |
0 |
0.00 |
7 |
2.62 |
10 |
3.79 |
7 |
4.64 |
1 |
1.96 |
0 |
0.00 |
0.847† |
Donor Characteristics |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gender |
|
|
|
|
|
|
|
|
|
|
|
|
0.331 |
Female |
11 |
47.83 |
98 |
36.70 |
116 |
43.94 |
65 |
43.05 |
17 |
33.33 |
6 |
54.55 |
|
Race |
|
|
|
|
|
|
|
|
|
|
|
|
0.182† |
African American |
6 |
26.09 |
21 |
7.87 |
23 |
8.71 |
16 |
10.60 |
5 |
9.80 |
0 |
0.00 |
|
White |
5 |
21.74 |
32 |
11.99 |
37 |
14.02 |
21 |
13.91 |
8 |
15.69 |
3 |
27.27 |
|
Other |
12 |
52.17 |
214 |
80.15 |
204 |
77.27 |
114 |
75.50 |
38 |
74.51 |
8 |
72.73 |
|
Age (years) |
|
|
|
|
|
|
|
|
|
|
|
|
0.051† |
≤ 18 |
4 |
17.39 |
50 |
18.73 |
41 |
15.53 |
11 |
7.28 |
8 |
15.69 |
0 |
0.00 |
|
19 - 30 |
6 |
26.09 |
81 |
30.34 |
62 |
23.48 |
44 |
29.14 |
11 |
21.57 |
2 |
18.18 |
|
31 - 44 |
7 |
30.43 |
72 |
26.97 |
80 |
30.30 |
42 |
27.81 |
12 |
23.53 |
4 |
36.36 |
|
45 - 59 |
6 |
26.09 |
57 |
21.35 |
68 |
25.76 |
48 |
31.79 |
15 |
29.41 |
3 |
27.27 |
|
≥ 60 |
0 |
0.00 |
7 |
2.62 |
13 |
4.92 |
6 |
3.97 |
5 |
9.80 |
2 |
18.18 |
|
Missing |
|
|
|
|
|
|
|
|
|
|
|
|
|
BMI category (kg/m2) |
|
|
|
|
|
|
|
|
|
|
|
|
0.720 |
≥ 10 to < 25 |
11 |
47.83 |
147 |
55.06 |
132 |
50.00 |
73 |
48.34 |
24 |
47.06 |
3 |
27.27 |
|
≥ 25 to < 30 |
7 |
30.43 |
77 |
28.84 |
80 |
30.30 |
45 |
29.80 |
18 |
35.29 |
4 |
36.36 |
|
≥ 30 |
5 |
21.74 |
43 |
16.10 |
52 |
19.70 |
33 |
21.85 |
9 |
17.65 |
4 |
36.36 |
|
Death due to stroke |
4 |
17.39 |
94 |
35.21 |
109 |
41.29 |
60 |
39.74 |
20 |
39.22 |
6 |
54.55 |
0.173 |
Terminal Creatinine ≥ 1.5 |
3 |
13.04 |
27 |
10.11 |
34 |
12.88 |
18 |
11.92 |
8 |
15.69 |
2 |
18.18 |
0.825 |
Hypertension history |
4 |
17.39 |
47 |
17.60 |
56 |
21.21 |
31 |
20.53 |
9 |
17.65 |
2 |
18.18 |
0.925 |
Diabetes |
0 |
0.00 |
4 |
1.50 |
9 |
3.41 |
7 |
4.64 |
3 |
5.88 |
0 |
0.00 |
0.276† |
CMV Status |
|
|
|
|
|
|
|
|
|
|
|
|
0.619† |
Sero-positive |
13 |
0.00 |
156 |
1.50 |
153 |
0.76 |
102 |
0.66 |
33 |
0.00 |
5 |
0.00 |
|
Missing |
0 |
56.52 |
4 |
58.43 |
2 |
57.95 |
1 |
67.55 |
0 |
64.71 |
0 |
45.45 |
|
Transplant Factors |
|
|
|
|
|
|
|
|
|
|
|
|
|
Donor type |
|
|
|
|
|
|
|
|
|
|
|
|
0.028† |
SCD |
22 |
95.65 |
238 |
89.14 |
220 |
83.33 |
128 |
84.77 |
40 |
78.43 |
9 |
81.82 |
|
ECD |
1 |
4.35 |
16 |
5.99 |
35 |
13.26 |
10 |
6.62 |
8 |
15.69 |
2 |
18.18 |
|
DCD |
0 |
0.00 |
13 |
4.87 |
9 |
3.41 |
13 |
8.61 |
3 |
5.88 |
0 |
0.00 |
|
Peak PRA |
|
|
|
|
|
|
|
|
|
|
|
|
0.331† |
0-10% |
16 |
69.57 |
215 |
80.52 |
209 |
79.17 |
112 |
74.17 |
42 |
82.35 |
10 |
90.91 |
|
11-30% |
1 |
4.35 |
22 |
8.24 |
21 |
7.95 |
16 |
10.60 |
5 |
9.80 |
1 |
9.09 |
|
>30% |
4 |
17.39 |
27 |
10.11 |
31 |
11.74 |
20 |
13.25 |
2 |
3.92 |
0 |
0.00 |
|
Unknown |
2 |
8.70 |
3 |
1.12 |
3 |
1.14 |
3 |
1.99 |
2 |
3.92 |
0 |
0.00 |
|
CMV sero-pairing |
|
|
|
|
|
|
|
|
|
|
|
|
0.668† |
Unknown |
1 |
4.35 |
23 |
8.61 |
17 |
6.44 |
7 |
4.64 |
2 |
3.92 |
1 |
9.09 |
|
Donor - / Recipient - |
5 |
21.74 |
48 |
17.98 |
43 |
16.29 |
19 |
12.58 |
6 |
11.76 |
3 |
27.27 |
|
Donor - / Recipient + |
5 |
21.74 |
49 |
18.35 |
61 |
23.11 |
28 |
18.54 |
12 |
23.53 |
2 |
18.18 |
|
Donor + / Recipient - |
5 |
21.74 |
72 |
26.97 |
66 |
25.00 |
35 |
23.18 |
15 |
29.41 |
3 |
27.27 |
|
Donor + / Recipient + |
7 |
30.43 |
75 |
28.09 |
77 |
29.17 |
62 |
41.06 |
16 |
31.37 |
2 |
18.18 |
|
HLA Mismatches |
|
|
|
|
|
|
|
|
|
|
|
|
0.884† |
0 HLA mismatches |
1 |
4.35 |
46 |
17.23 |
38 |
14.39 |
31 |
20.53 |
8 |
15.69 |
0 |
0.00 |
|
1 HLA mismatches |
0 |
0.00 |
4 |
1.50 |
4 |
1.52 |
1 |
0.66 |
0 |
0.00 |
0 |
0.00 |
|
2 HLA mismatches |
0 |
0.00 |
19 |
7.12 |
16 |
6.06 |
8 |
5.30 |
2 |
3.92 |
0 |
0.00 |
|
3 HLA mismatches |
8 |
34.78 |
38 |
14.23 |
41 |
15.53 |
18 |
11.92 |
7 |
13.73 |
3 |
27.27 |
|
4 HLA mismatches |
7 |
30.43 |
58 |
21.72 |
54 |
20.45 |
36 |
23.84 |
14 |
27.45 |
3 |
27.27 |
|
5 HLA mismatches |
5 |
21.74 |
69 |
25.84 |
81 |
30.68 |
40 |
26.49 |
14 |
27.45 |
4 |
36.36 |
|
6 HLA mismatches |
2 |
8.70 |
33 |
12.36 |
30 |
11.36 |
17 |
11.26 |
6 |
11.76 |
1 |
9.09 |
|
Sensitized |
3 |
13.04 |
23 |
8.61 |
22 |
8.33 |
11 |
7.28 |
1 |
1.96 |
0 |
0.00 |
0.486† |
Cold Ischemia Time |
|
|
|
|
|
|
|
|
|
|
|
|
0.448† |
0 to < 15 hours |
8 |
34.78 |
111 |
41.57 |
99 |
37.50 |
64 |
42.38 |
25 |
49.02 |
7 |
63.64 |
|
15 to < 20 hours |
4 |
17.39 |
57 |
21.35 |
54 |
20.45 |
29 |
19.21 |
9 |
17.65 |
1 |
9.09 |
|
20 to < 26 hours |
3 |
13.04 |
32 |
11.99 |
36 |
13.64 |
23 |
15.23 |
10 |
19.61 |
0 |
0.00 |
|
26+ hours |
3 |
13.04 |
14 |
5.24 |
24 |
9.09 |
15 |
9.93 |
3 |
5.88 |
0 |
0.00 |
|
Unknown |
5 |
21.74 |
53 |
19.85 |
51 |
19.32 |
20 |
13.25 |
4 |
7.84 |
3 |
27.27 |
|
Year‡ |
|
|
|
|
|
|
|
|
|
|
|
|
0.696† |
2000 |
1 |
2.78 |
18 |
50.00 |
10 |
27.78 |
6 |
16.67 |
1 |
2.78 |
0 |
0.00 |
|
2001 |
3 |
4.41 |
29 |
42.65 |
15 |
22.06 |
15 |
22.06 |
4 |
5.88 |
2 |
2.94 |
|
2002 |
5 |
5.10 |
32 |
32.65 |
37 |
37.76 |
18 |
18.37 |
5 |
5.10 |
1 |
1.02 |
|
2003 |
3 |
2.65 |
35 |
30.97 |
40 |
35.40 |
26 |
23.01 |
7 |
6.19 |
2 |
1.77 |
|
2004 |
4 |
3.39 |
45 |
38.14 |
41 |
34.75 |
19 |
16.10 |
9 |
7.63 |
0 |
0.00 |
|
2005 |
3 |
2.50 |
41 |
34.17 |
51 |
42.50 |
15 |
12.50 |
7 |
5.83 |
3 |
2.50 |
|
2006 |
3 |
2.03 |
46 |
31.08 |
48 |
32.43 |
37 |
25.00 |
12 |
8.11 |
2 |
1.35 |
|
2007 |
1 |
1.52 |
21 |
31.82 |
22 |
33.33 |
15 |
22.73 |
6 |
9.09 |
1 |
1.52 |
|
† Fisher’s Exact Test
‡ Proportion displayed by rows. All other variables displayed by column.
PKD – Polycystic Kidney Disease |